Single Adductor-canal-block Versus Peri-articular Infiltration on Outcome After Total Knee Arthroplasty
Comparison of the Effect of Single Adductor-canal-block and Peri-articular Infiltration on the Outcome After Unilateral Total Knee Arthroplasty
1 other identifier
interventional
200
1 country
1
Brief Summary
The purpose of this study is to compare the effect of single adductor-canal-block versus single femoral nerve block on the recovery after total knee arthroplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 15, 2016
CompletedFirst Posted
Study publicly available on registry
May 26, 2016
CompletedStudy Start
First participant enrolled
September 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedApril 6, 2017
April 1, 2016
1.2 years
May 15, 2016
April 4, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the time required for functional recovery
Patients are evaluated postoperatively to determine whether the patients have meet the criteria of functional recovery.The criteria of functional recovery are as followings: walking distance more than 70m with crutch, getting up or standing up independently and visual analog score less than 5 both in rest and after movement. Before discharge, patients are assessed every morning. After discharge, patients are followed up by phone every two days.
from the date of the surgery to the time when the patients meet the criteria of functional recovery. The earliest day on which the patient achieves the criteria of functional recovery will be recorded and the average time is 7 days after surgery.
Secondary Outcomes (5)
postoperative WOMAC scales
pre-operative, three months,six months and one year afer the surgery
Postoperative complications
daily after the surgery until discharge from hospital, expected average up to 5 days after the surgery
postoperative VAS scale
pre-operative, 6h postoperative, 24h postoperative, 48h postoperative, one month postoperative, three-month postoperative, one year postoperative
postoperative morphine consumption
6h, 24h, 48h after the surgery
postoperative SF-36 score
pre-operative, three months,six months and one year afer the surgery
Other Outcomes (1)
patients' satisfaction
before discharge, usually 3-4 days after the surgery and one year after the surgery
Study Arms (2)
single adductor-canal-block
EXPERIMENTALPatients in this group will receive ultrasound guided single adductor-canal- block with 0.35% ropivacaine 25ml.
periarticular infiltration
EXPERIMENTALpatients in this group will receive periarticular infiltration of local anesthetic.
Interventions
Single adductor-canal-block is performed before the surgery. A 12Hz linear ultrasound transducer is placed on the medial part of the thigh with the leg slightly externally rotated. The femoral artery was identified in short axis in the adductor canal, underneath the sartorius muscle. After skin disinfection , an 18-gauge needle (B.Braun Medical, Melsungen, Germany) is inserted in-plane from the lateral side of the transducer. The needle tip was placed underneath the sartorius muscle, just lateral to the artery and saphenous nerve, using 2-3 ml of saline to ensure correct placement. 25 ml of 0.35% ropivacaine is slowly injected with repeated aspiration.
The periarticular infiltration of multimodal agents will involve the preparation of a mixture of 100 ml solution. The mixture contains 30ml (300mg) ropivacaine, 0.5ml (5 mg) morphine, 2 ml (50 mg) flurbiprofen and 0.5 ml of 1:1000 epinephrine, and then is diluted with 0.9% normal saline to a total volume of 100ml. 50 ml of mixture will be injected into the anterior, medial and lateral soft tissues after the implantation of the joint prostheses. The remaining 50 ml of mixture will be injected into intraarticular space after the closure of articular capsule.
Eligibility Criteria
You may qualify if:
- osteoarthritis
- unilateral total knee arthroplasty
- ASA grade I - II
- normal cognitive function.
You may not qualify if:
- patients refuse
- BMI \> 35
- diagnosis other than osteoarthritis
- allergy to the drugs used or contraindication to the intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking Union Medical College Hospital
Beijing, 100730, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yuguang Huang, Dr
Peking Union Medical College Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2016
First Posted
May 26, 2016
Study Start
September 1, 2016
Primary Completion
December 1, 2017
Study Completion
December 1, 2018
Last Updated
April 6, 2017
Record last verified: 2016-04
Data Sharing
- IPD Sharing
- Will share